Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer

被引：0
作者：
Hidetaka Nomura
Ai Ikki
Atsushi Fusegi
Makiko Omi
Yoichi Aoki
Sachiho Netsu
Terumi Tanigawa
Maki Matoda
Sanshiro Okamoto
Kohei Omatsu
Takeshi Nakajima
Arisa Ueki
Akiko Tonooka
Hiroyuki Kanao
机构：
[1] Cancer Institute Hospital,Department of Gynecology
[2] Japanese Foundation for Cancer Research,Department of Clinical Genetics
[3] Cancer Institute Hospital,Division of Pathology
[4] Japanese Foundation for Cancer Research,undefined
[5] Cancer Institute,undefined
[6] Japanese Foundation for Cancer Research,undefined
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Hereditary breast and ovarian cancer; Ovarian cancer; Risk-reducing surgery; Surveillance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2331 / 2337
页数：6
相关论文
共 74 条
[1]  
Chen S(2007)Meta-analysis of J Clin Oncol 25 1329-1333
[2]  
Parmigiani G(2020) and JNCI Cancer Spectr 30 2654-2663
[3]  
Chen J(2012) penetrance J Clin Oncol 29 1043-1049
[4]  
Bae E(2019)Penetrance of breast and ovarian cancer in women who carry a Int J Gynecol Cancer 105 141-148
[5]  
Zhang L(2013) mutation and do not use risk-reducing salpingo-oophorectomy: an updated meta-analysis J Natl Cancer Inst 10 639-47
[6]  
Alsop K(2016) mutation frequency and patterns of treatment response in Ecancermedicalscience 12 40-26
[7]  
Fereday S(2019) mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group J Ovarian Res 140 42-5596
[8]  
Meldrum C(2016)The first Japanese nationwide multicenter study of Gynecol Oncol 100 20-1221
[9]  
Enomoto T(2006) mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer genetic Testing of Gynecol Oncol 23 5586-975
[10]  
Aoki D(2005) (CHARLOTTE) J Clin Oncol 118 1212-87
12345678